Skip to main
SNSS
SNSS logo

Sunesis Pharmaceuticals (SNSS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Sunesis Pharmaceuticals (SNSS) Stock

About Sunesis Pharmaceuticals (SNSS)

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Market cap$437.2K
Today's volume
Revenue (TTM)
Avg. daily volume116.2K
EBITDA (TTM)-$46.07M
Open
Price / earnings ratio-0.01x
Today's range
Debt / equity
52 week range$0.01 - $0.58
5 year debt / equity
Beta (LTM)0.62x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.76x
Ex-dividend date
Next earningsNov 16, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 12, 2025, the market cap for SNSS stock is $437.2K

The current P/E ratio for SNSS stock is -0.01

The 52-week high for SNSS stock is $0.58. The current SNSS stock price $undefined is 100.00% below its 52-week high

The 52-week low for SNSS stock is $0.01. The current SNSS stock price $undefined has increased 100.00% from its 52-week low

No, the SNSS stock does not pay dividends to its shareholders

How to buy SNSS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SNSS stock

    Navigate to the Explore page. Then, type SNSS into the search bar. When you see SNSS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SNSS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Sunesis Pharmaceuticals Stock Earnings

The value each SNSS share was expected to gain vs. the value that each SNSS share actually gained.

Sunesis Pharmaceuticals (SNSS) reported Q3 2020 earnings per share (EPS) of -$0.29, beating estimates of -$0.34 by 14.71%. In the same quarter last year, Sunesis Pharmaceuticals's earnings per share (EPS) was $0. Sunesis Pharmaceuticals is expected to release next earnings on 11/16/2020, with an earnings per share (EPS) estimate of $0.

Buy Sunesis Pharmaceuticals (SNSS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.